The largest health insurer in the United States, UnitedHealth, plans to spend more than US$12 billion to buy pharmacy benefits manager Catamaran Corp., one of the top healthcare stocks listed on the Toronto Stock Exchange.
Vontobel Asset Management has agreed to acquire a 60% stake in TwentyFour Asset Management LLP, an independent fixed income specialist based in London.
Canada’s Valeant Pharmaceuticals International has raised its bid to acquire Salix Pharmaceuticals for about US$11.1 billion ($14.2 billion).
Dublin-based Endo International has made an unsolicited bid to acquire Salix Pharmaceuticals for about US$11 billion.
AbbVie, which terminated its deal to purchase Shire last year, has agreed to acquire Pharmacyclics for US$21 billion.
Mercer has acquired a 9.9% stake in Benefitfocus, a U.S. provider of cloud-based benefits software solutions, for US$74.7 million.
After failing to buy Allergan, Canada's Valeant Pharmaceuticals International has agreed to purchase Salix Pharmaceuticals for US$14.5 billion.
Fiera Capital is buying New York-based Samson Capital Advisors for about US$33.5 million.
U.S. drugstore retailer Rite Aid has agreed to purchase EnvisionRx, a pharmacy benefit management firm, for US$2 billion.
Great-West Lifeco Inc.'s European subsidiary, Canada Life Group, has reached an agreement to acquire Legal & General International (Ireland) Ltd. (LGII).